Hôpital Saint Antoine AP-HP

56 currently recruiting clinical trials
Create patient profile for matching
Phase 3 Colon cancer Rectal cancer #NCT05253651 #2024-514180-25-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
HER2
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
KRAS G12C KRAS non G12C NRAS
Hôpital Saint Antoine AP-HP (Paris)
Seagen
Phase 3 Liver and bile duct cancer #NCT06813976
Required histologic sub types
Ampullary carcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Hôpital Saint Antoine AP-HP (Paris)
CHU Dijon
Phase 3 Rectal cancer #NCT06762405
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized Locally Advanced
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Immunotherapy Chemotherapy Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy Radiotherapy
Hôpital Saint Antoine AP-HP (Paris)
CHU Dijon
Phase 2 / Phase 3 Multiple myeloma #NCT07095452 #2025-520897-21-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required central nervous system lesions
None
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Required IMWG cytogenetic prognoses
High risk
Hôpital Saint Antoine AP-HP (Paris)
Abbvie
Phase 2 / Phase 3 Colon cancer Rectal cancer #NCT05462613 #2024-516709-22-00
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Surgery Chemotherapy Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Saint Antoine AP-HP (Paris)
CHU de Besançon
Phase 2 Multiple myeloma #NCT07227311 #2025-523117-28-00
Cohorte BVd (Belantamab mafodotin + Bortezomib + Dexamethasone)
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required number of previous lines of therapy
1 2
Excluded previous treatments
Systemic Treatment-Naive Allogeneic stem cell transplant
Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2 Multiple myeloma #NCT07227311 #2025-523117-28-00
Cohorte BKd (Belantamab mafodotin + Carfilzomib + dexaméthasone)
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required number of previous lines of therapy
1 2
Excluded previous treatments
Systemic Treatment-Naive Allogeneic stem cell transplant
Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2 Multiple myeloma #NCT07227311 #2025-523117-28-00
Cohorte BPd (Belantamab + Pomalidomide + Dexamethasone))
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required number of previous lines of therapy
1 2
Required previous treatments
Immunomodulator
Excluded previous treatments
Systemic Treatment-Naive Allogeneic stem cell transplant
Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2 Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Sarcoma and GIST Small intestine and appendix cancer #NCT06333314 #2023-505298-34-00
Required histologic types
Stomach Oesogastric junction Soft tissue sarcoma
Required histologic sub types
Adenocarcinoma Ampullary carcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required CPS scores
CPS Negative (< 1) CPS Positive (1 <= X < 5)
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Radiotherapy
Hôpital Saint Antoine AP-HP (Paris)
UNICANCER
Phase 2 Prostate cancer Colon cancer Rectal cancer Anal cancer Pancreas cancer Stomach and esophageal cancer Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer #NCT06333314 #2023-505298-34-00
Required histologic sub types
Neuroendocrine carcinoma
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Radiotherapy
Hôpital Saint Antoine AP-HP (Paris)
UNICANCER